Jim Simons Crispr Therapeutics Ag Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$60.67 - $89.12 $339,691 - $498,982	5,599 New	5,599 $382,000
Q3 2023 Nov 14, 2023	SELL	$45.39 - $59.0 $6.57 Million - $8.54 Million	-144,733 Reduced 50.29%	143,067 $6.49 Million
Q2 2023 Aug 11, 2023	SELL	$43.47 - $67.77 $9.01 Million - $14 Million	-207,303 Reduced 41.87%	287,800 $16.2 Million
Q1 2023 May 12, 2023	SELL	$41.0 - $56.12 $12 Million - $16.4 Million	-291,497 Reduced 37.06%	495,103 $22.4 Million
Q4 2022 Feb 13, 2023	BUY	$39.19 - $65.67 $7.58 Million - $12.7 Million	193,300 Added 32.58%	786,600 $32 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $1.5 Million - $2.06 Million	24,600 Added 4.33%	593,300 $38.8 Million
Q2 2022 Aug 12, 2022	SELL	$43.23 - $73.83 $5.78 Million - $9.86 Million	-133,600 Reduced 19.02%	568,700 $34.6 Million
Q1 2022 May 13, 2022	BUY	$53.19 - $79.24 $6.57 Million - $9.78 Million	123,458 Added 21.33%	702,300 $44.1 Million
Q4 2021 Feb 11, 2022	BUY	$70.09 - $111.29 $40.6 Million - $64.4 Million	578,842 New	578,842 $43.9 Million
Q2 2021 Aug 13, 2021	SELL	$100.84 - $161.89 $12.4 Million - $19.9 Million	-123,110 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$110.72 - $210.04 $3.33 Million - $6.32 Million	-30,090 Reduced 19.64%	123,110 $15 Million
Q4 2020 Feb 10, 2021	SELL	$79.67 - $173.23 $19.2 Million - $41.8 Million	-241,500 Reduced 61.19%	153,200 $23.5 Million
Q3 2020 Nov 13, 2020	BUY	$78.5 - $100.64 $2.04 Million - $2.62 Million	26,042 Added 7.06%	394,700 $33 Million
Q2 2020 Aug 13, 2020	SELL	$38.5 - $76.05 $5.41 Million - $10.7 Million	-140,517 Reduced 27.6%	368,658 $27.1 Million
Q1 2020 May 14, 2020	BUY	$33.68 - $62.53 $3.86 Million - $7.17 Million	114,611 Added 29.05%	509,175 $21.6 Million
Q4 2019 Feb 13, 2020	BUY	$36.68 - $73.13 $13 Million - $26 Million	355,264 Added 903.98%	394,564 $24 Million
Q3 2019 Nov 13, 2019	BUY	$40.99 - $52.56 $1.61 Million - $2.07 Million	39,300 New	39,300 $1.61 Million
Q1 2019 May 14, 2019	SELL	$28.02 - $40.87 $319,428 - $465,917	-11,400 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$22.73 - $42.34 $259,122 - $482,676	11,400 New	11,400 $326,000

Others Institutions Holding CRSP

# of Institutions

485

Shares Held

57.5M

Call Options Held

1.09M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$317 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$300 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$120 Million
0.01% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$119 Million
1.61% of portfolio
Black Rock Inc. New York, NY

2.78M
Shares

$111 Million
0.0% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.12B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account